Catalyst Wire Dossier Catalyst Wire Dossier

Genetically Modified Haploidentical Natural Killer Cell Infusion

genetically modified haploidentical natural killer cells · St. Jude Children's Research Hospital
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Genetically Modified Haploidentical Natural Killer Cell Infusion, covering 2017-04-26 to 2017-04-26. Get the full timeline:

Most recent: Clinical Trial Update: Genetically Modified Haploidentical Natural Killer Cell Infusions for B-Lineage Acute Lymphoblastic Leukemia [Phase 1]

See pricing